These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 12185052

  • 1. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
    Schima W, Függer R, Schober E, Oettl C, Wamser P, Grabenwöger F, Ryan JM, Novacek G.
    AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions.
    Boraschi P, Donati F, Gigoni R, Salemi S, Faggioni L, Del Chiaro M, Boggi U, Bartolozzi C, Falaschi F.
    Dig Liver Dis; 2009 Nov; 41(11):829-37. PubMed ID: 19303825
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT.
    Rieber A, Tomczak R, Nüssle K, Klaus H, Brambs HJ.
    Br J Radiol; 2000 Nov; 73(875):1165-9. PubMed ID: 11144793
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT.
    Schima W, Függer R.
    Eur Radiol; 2002 Dec; 12(12):2998-3008. PubMed ID: 12439582
    [Abstract] [Full Text] [Related]

  • 8. Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis.
    Braga HJ, Choti MA, Lee VS, Paulson EK, Siegelman ES, Bluemke DA.
    Radiology; 2002 May; 223(2):525-31. PubMed ID: 11997563
    [Abstract] [Full Text] [Related]

  • 9. Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.
    Oudkerk M, Torres CG, Song B, König M, Grimm J, Fernandez-Cuadrado J, Op de Beeck B, Marquardt M, van Dijk P, de Groot JC.
    Radiology; 2002 May; 223(2):517-24. PubMed ID: 11997562
    [Abstract] [Full Text] [Related]

  • 10. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging.
    Kim SK, Kim SH, Lee WJ, Kim H, Seo JW, Choi D, Lim HK, Lee SJ, Lim JH.
    AJR Am J Roentgenol; 2002 Sep; 179(3):741-50. PubMed ID: 12185056
    [Abstract] [Full Text] [Related]

  • 11. Identification and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium-enhanced magnetic resonance imaging.
    Ramsay D, Marshall M, Song S, Zimmerman M, Edmunds S, Yusoff I, Cullingford G, Fletcher D, Mendelson R.
    Australas Radiol; 2004 Jun; 48(2):154-61. PubMed ID: 15230749
    [Abstract] [Full Text] [Related]

  • 12. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
    Kim HJ, Kim KW, Byun JH, Won HJ, Shin YM, Kim PN, Lee MS, Lee MG.
    AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579
    [Abstract] [Full Text] [Related]

  • 13. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer.
    Koelblinger C, Ba-Ssalamah A, Goetzinger P, Puchner S, Weber M, Sahora K, Scharitzer M, Plank C, Schima W.
    Radiology; 2011 Jun; 259(3):757-66. PubMed ID: 21436084
    [Abstract] [Full Text] [Related]

  • 14. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
    Zanello A, Nicoletti R, Brambilla P, Boccuni R, Di Carlo V, Staudacher C, Del Maschio A.
    Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
    [Abstract] [Full Text] [Related]

  • 15. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C.
    Acta Radiol Suppl; 1998 Sep; 415():1-31. PubMed ID: 9571956
    [Abstract] [Full Text] [Related]

  • 16. Mangafodipir-DPDP enhanced MRI visualization of a pancreatic adenocarcinoma previously undetected by extracellular contrast enhanced CT and MRI.
    De Filippo M, Bocchi C, Quartieri L, Corradi D, Zompatori M.
    Acta Biomed; 2007 Dec; 78(3):225-8. PubMed ID: 18330084
    [Abstract] [Full Text] [Related]

  • 17. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
    Motosugi U, Ichikawa T, Morisaka H, Sou H, Muhi A, Kimura K, Sano K, Araki T.
    Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
    [Abstract] [Full Text] [Related]

  • 18. Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging--ROC analysis.
    Nishiharu T, Yamashita Y, Abe Y, Mitsuzaki K, Tsuchigame T, Nakayama Y, Takahashi M.
    Radiology; 1999 Aug; 212(2):445-52. PubMed ID: 10429702
    [Abstract] [Full Text] [Related]

  • 19. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience.
    Yeh BM, Breiman RS, Taouli B, Qayyum A, Roberts JP, Coakley FV.
    Radiology; 2004 Mar; 230(3):645-51. PubMed ID: 14990830
    [Abstract] [Full Text] [Related]

  • 20. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Kim MJ, Kim JH, Lim JS, Oh YT, Chung JJ, Choi JS, Lee WJ, Kim KW.
    J Magn Reson Imaging; 2004 Oct; 20(4):612-21. PubMed ID: 15390224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.